Paul Marantz, M.D., M.P.H., a longtime leader in clinical and translational science education at Albert Einstein College of Medicine, was inducted as an inaugural Fellow of the Association for Clinical and Translational Science (FACTS) on April 21. Dr. Marantz is professor of epidemiology and population health and of medicine at Einstein.

Dr. Marantz was among 36 individuals selected through a competitive process from nearly 6,000 Association for Clinical and Translational Science (ACTS) members nationwide. ACTS is a nonprofit organization that supports research, education, advocacy, and mentoring in clinical and translational science. The FACTS program recognizes professionals who have made significant contributions to the field and to the broader translational science community.

Over a career spanning more than three decades, Dr. Marantz has played a pivotal role in shaping the training of translational investigators at Einstein and across the United States. Initially trained as a clinical epidemiologist studying heart failure, he later focused on advancing education in evidence-based medicine, clinical skills, and preventive medicine.

While on sabbatical from Einstein in 1995, he worked at the National Institutes of Health Office of Disease Prevention and helped inform early frameworks for training programs that ultimately evolved into the Clinical and Translational Science Awards (CTSA) program. He became the founding director of Einstein’s Clinical Research Training Program, which leads to a master’s degree in clinical research methods, in 1998.  In 2011, he was given the Distinguished Educator Award by the Association for Clinical Research Training, and in 2014, he received Einstein’s Faculty Mentoring Award.

ACTS President Allan R. Brasier, M.D., said the fellowship honors individuals whose impact on translational science is “undeniable” and reflects the organization’s commitment to innovation, collaboration, and community.